key: cord-0946430-vp4s1nka
authors: Yammine, Halim; Ballast, Jocelyn K.; Poulsen, Neil; Arko, Frank R.
title: EVAR in an asymptomatic COVID-19 positive patient with a symptomatic inflammatory abdominal aortic aneurysm
date: 2020-09-02
journal: J Vasc Surg Cases Innov Tech
DOI: 10.1016/j.jvscit.2020.08.016
sha: 5d35db9e4ddcc979d6cefac65cf9a0d7c18e78ca
doc_id: 946430
cord_uid: vp4s1nka

In this report, we present the case of a COVID-19 positive patient whose symptomatic inflammatory AAA (abdominal aortic aneurysm) was successfully treated with EVAR (endovascular aortic repair) at our institution. We will discuss the reasoning behind the type of therapy used and the various lessons learned.

The Covid-19 pandemic has swept the nation and the whole planet in the past few 2 months. Despite it being predominantly a respiratory illness, the vascular system is also impacted 3 by the disease with reports of spontaneous arterial and venous thrombosis [1] [2] [3] [4] . Here we describe 4 the case of an asymptomatic COVID-19 patient who was treated at our institution for a 5 symptomatic inflammatory AAA (abdominal aortic aneurysm). The patient consented to the 6 publication of these case details. 7 Case report 8 A 65-year-old Caucasian male presented to an outside institution with symptoms of lower 9 abdominal pain radiating to his back. He had known chronic back pain, but in the past 4 days his 10 pain had worsened, prompting him to go to the emergency room. There, a CTA (computed 11 tomography angiogram) of the abdomen and pelvis (figure 1) was obtained, showing a 5.3 cm 12 inflammatory AAA. The patient was accepted to transfer to our facility. Per our hospital's 13 protocol, he was tested for COVID-19 as soon as he arrived at the floor and his surgery was 14 delayed by 24 hours until we obtained the results. The patient tested positive for COVID-19, 15 though he did not have any respiratory symptoms nor any other of the typical symptoms usually 16 associated with the disease.

He underwent a successful percutaneous EVAR (endovascular aortic repair (figure 2) on 18 hospital day 2 in less than 30 hours from his admission. In order to reduce the thrombotic 19 complications associated with COVID-19, he received a larger than usual dose of heparin 20 intraoperatively and was discharged home on post-operative day 1 on subcutaneous Lovenox.

His symptoms resolved after the procedure. There are two reports in the literature about EVAR in ruptured AAA in COVID-19 19 positive patients but neither involved inflammatory AAA 5,6 . Our patient's D-Dimer levels were 20 elevated (2.23 ug FEU/ml) as well as the CRP level which was mildly elevated (0.9 mg/dl).

Although not previously described, we wonder whether the inflammation associated with this these reports, we elected to give the patient higher than usual doses of heparin intraoperatively 9 and kept the activated clotting time (ACT) greater than 300 seconds during the case. In addition, 10 we started him on subcutaneous Lovenox (40mg daily) that evening to continue for 14 days after 11 his surgery. While more data is necessary to support the correlation between COVID-19 and 12 arterial and venous thrombosis and the value of prophylactic anticoagulation, we felt that in the 13 presence of multiple reports of increased clotting, it was prudent in this case to take steps to 14 decrease the risk of limb thrombosis. Given the fact that the patient did not have a thrombotic 15 event, and the higher risk for bleeding complications with the full dose we decided to go with the 16 prophylactic dose. There is no data to support either choice or to help determine the duration of 17 treatment.

Finally, another aspect to consider while dealing with symptomatic or ruptured AAA is 19 health care worker's safety. These cases are typically emergently transferred to tertiary or 20 quaternary referral centers such as ours, sometimes in the middle of the night. In the case of a transfers. Our patient was not tested for COVID-19 at the institution where he presented due to 4 lack of typical symptoms, but he tested positive once he arrived at our facility, where we 5 routinely test patients undergoing procedures. Despite wearing a regular surgical mask and 6 gloves when examining the patient before the test results came back, no face shields or N-95 7 masks were worn, allowing health care workers to potentially have been exposed. The lack of 8 uniform testing across institutions suggests that special care needs to be taken care with 9 emergently transferred patients, including, perhaps, new institutional policies to protect health 10 care workers. 

Coagulopathy of Coronavirus Disease 2